Lung surfactant in subacute pulmonary disease

Respiratory Research

Volumn 3, Issue , 2002, Pages

  Devendra, Gehan ^a   Spragg, Roger G ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Asthma; Interstitial pulmonary fibrosis; Pneumonia; Pulmonary alveolar proteinosis; Pulmonary surfactant

Indexed keywords

CIGARETTE SMOKE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LUNG SURFACTANT; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT RESPIRATORY DISTRESS SYNDROME; ALLERGIC PNEUMONITIS; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS PROTEINOSIS; LUNG DISEASE; LUNG FIBROSIS; LUNG LAVAGE; LUNG SARCOIDOSIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; NONHUMAN; PATHOPHYSIOLOGY; PILOT STUDY; PNEUMONIA; PROTEIN ANALYSIS; PROTEIN CONTENT; REVIEW; RISK ASSESSMENT; RISK FACTOR; FIBROSING ALVEOLITIS; SMOKING;

EID: 0037761662     PISSN: 1465993X     EISSN: None     Source Type: Journal    
DOI: 10.1186/rr168     Document Type: Review

References (31)

1. Crouch E, Wright JR: Surfactant proteins A and D and pulmonary host defense. Annu Rev Physiol 2001, 63:521-554
2. Enhorning G, Duffy LC, Welliver RC: Pulmonary surfactant maintains patency of conducting airways in the rat. Am J Respir Crit Care Med 1995, 151:554-556
3. Veletza SV, Rogan PK, TenHave T, Olowe SA, Floros J: Racial differences in allelic distribution at the human pulmonary surfactant protein B gene locus (SP-B). Exp Lung Res 1996, 22:489-494
4. Nogee LM, Dunbar AE, Wert SE, Askin F, Hamvas A, Whitsett JA: A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 2001, 344:573-579
5. Wang Z, Notter RH: Additivity of protein and nonprotein inhibitors of lung surfactant activity. Am J Respir Crit Care Med 1998, 158:28-35
6. Zhu S, Basiouny KF, Crow JP, Matalon S: Carbon dioxide enhances nitration of surfactant protein A by activated alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 2000, 278:L1025-L1031
7. Hohlfeld J, Fabel H, Hamm H: The role of pulmonary surfactant in obstructive airways disease. Eur Respir J 1997, 10:482-491
8. Kurashima K, Fujimura M, Matsuda T, Kobayashi T: Surface activity of sputum from acute asthmatic patients. Am J Respir Crit Care Med 1997, 155:1254-1259
9. Liu M, Wang L, Enhorning G: Surfactant dysfunction develops when the immunized guinea-pig is challenged with ovalbumin aerosol. Clin Exp Allergy 1995, 25:1053-1060
10. Becher G: Lung surfactant prevents allergic bronchial constriction in ovalbumin sensitized guinea pigs. Biomed Biochim Acta 1985, 44:K57-K61
11. Cheng G, Ueda T, Sugiyama K, Toda M, Fukuda T: Compositional and functional changes of pulmonary surfactant in a guineapig model of chronic asthma. Respir Med 2001, 95:180-186
12. Oetomo SB, Dorrepaal C, Bos H, Gerritsen J, van der Mark TW, Koeter GH, van Aalderen WM: Surfactant nebulization does not alter airflow obstruction and bronchial responsiveness to histamine in asthmatic children. Am J Respir Crit Care Med 1996, 153:1148-1152
13. Kurashima K, Ogawa H, Ohka T, Fujimura M, Matsuda T, Kobayashi T: A pilot study of surfactant inhalation in the treatment of asthmatic attack. Arerugi 1991, 40:160-163
14. Wirtz HR, Schmidt M: Acute influence of cigarette smoke on secretion of pulmonary surfactant in rat alveolar type II cells in culture. Eur Respir J 1996, 9:24-32
15. Repine JE, Bast A, Lankhorst I: Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. Am J Respir Crit Care Med 1997, 156:341-357
16. Honda Y, Takahashi H, Kuroki Y, Akino T, Abe S: Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers. Chest 1996, 109:1006-1009
17. Anzueto A, Jubran A, Ohar JA, Piquette CA, Rennard SI, Colice G, Pattishall EN, Barrett J, Engle M, Perret KA, Rubin BK: Effects of aerosolized surfactant in patients with stable chronic bronchitis: a prospective randomized controlled trial. JAMA 1997, 278:1426-1431
18. Griese M, Birrer P, Demirsoy A: Pulmonary surfactant in cystic fibrosis. Eur Respir J 1997, 10:1983-1988
19. von Bredow C, Birrer P, Griese M: Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis. Eur Respir J 2001, 17:716-722
20. Griese M, Bufler P, Teller J, Reinhardt D: Nebulization of a bovine surfactant in cystic fibrosis: a pilot study. Eur Respir J 1997, 10:1989-1994
21. Schmidt R, Meier U, Yabut-Perez M, Walmrath D, Grimminger F, Seeger W, Günther A: Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia. Am J Respir Crit Care Med 2001, 163:95-100
22. Mikawa K, Maekawa N, Nishina K, Takao Y, Yaku H, Obara H: Selective intrabronchial instillation of surfactant in a patient with pneumonia: a preliminary report. Eur Respir J 1993, 6: 1563-1566
23. Günther A, Schmidt R, Nix F, Yabut-Perez M, Guth C, Rosseau S, Siebert C, Grimminger F, Morr H, Velcovsky HG, Seeger W: Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis. Eur Respir J 1999, 14:565-573
24. Takahashi H, Kuroki Y, Tanaka H, Saito T, Kurokawa K, Chiba H, Sagawa A, Nagae H, Abe S: Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis. Am J Respir Crit Care Med 2000, 162:258-263
25. McCormack FX, King TEJ, Bucher BL, Nielsen L, Mason RJ, Mc-Cormac FX: Surfactant protein A predicts survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1995, 152:751-759
26. Hamm H, Luhrs J, Guzman , Costabel U, Fabel H, Bartsch W: Elevated surfactant protein A in bronchoalveolar lavage fluids from sarcoidosis and hypersensitivity pneumonitis patients. Chest 1994, 106:1766-1770
27. Reed JA, Ikegami M, Cianciolo ER, Lu W, Cho PS, Hull W, Jobe AH, Whitsett JA: Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice. Am J Physiol 1999, 276:L556-L563
28. Kitamura T, Tanaka N, Watanabe J, Uchida K, Kanegasaki S, Yamada Y, Nakata K: Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med 1999, 190:875-880
29. Doyle IR, Davidson KG, Barr HA, Nicholas TE, Payne K, Pfitzner J: Quantity and structure of surfactant proteins vary among patients with alveolar proteinosis. Am J Respir Crit Care Med 1998, 157:658-664
30. Suzuki Y, Shen HQ, Sato A, Nagai S: Analysis of fused-membrane structures in bronchoalveolar lavage fluid from patients with alveolar proteinosis. Am J Respir Cell Mol Biol 1995, 12:238-249
31. Kavuru MS, Sullivan EJ, Piccin R, Thomassen MJ, Stoller JK: Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2000, 161:1143-1148